Jean-francois F. Baurain
Avenue Hippocrate 10
Brussels, BRU 1200, Belgium
Brussels, BRU 1200, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Tisotumab vedotin plus carboplatin or pembrolizumab in recurrent or metastatic cervical cancer: 5-year results from the innovaTV 205/ENGOT-cx8/GOG-3024 study.
Journal: Gynecologic oncology
Published: February 02, 2026
Correction: A case report of malignant hypertension and multiorgan dysfunction during immunotherapy for gallbladder cancer.
Journal: Frontiers in oncology
Published: December 18, 2025
Uveal melanoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up.
Journal: ESMO open
Published: September 24, 2025
Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors.
Journal: Cancer research communications
Published: September 12, 2025
Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial.
Journal: The Lancet. Oncology
Published: July 13, 2025
Immune checkpoint-induced arthritis: a comprehensive single-cohort descriptive analysis from clinical evaluation to histology.
Journal: Frontiers in medicine
Published: May 30, 2025
Adjuvant treatment algorithm based on recent ESGO/ESTRO/ESP guidelines for early endometrial carcinoma according to prognostic risk groups.
Journal: Journal of gynecologic oncology
Published: May 26, 2025
Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 12, 2025
Real-life data on tebentafusp in metastatic uveal melanoma patients from four EURACAN Expert Centres.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 09, 2025
Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer: a multicenter, single-arm phase 2a study.
Journal: Journal for immunotherapy of cancer
Published: December 23, 2024
A Phase I, First-in-Human, Dose-Escalation, Expansion Trial of Cytokine-Encoding Synthetic mRNA Mixture Alone or with Cemiplimab in Advanced Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 10, 2024
Last Updated: 09/26/2026